BrainsWay Secures FDA Approval for First At-Home Neuromodulation Device Targeting Resistant Depression
Market Chameleon (Mon, 12-Jan 8:44 AM)
BrainsWay’s Deep TMS Gains Broader Adolescent Depression Coverage as Optum Expands Policy
Market Chameleon (Mon, 22-Dec 10:15 AM)
